BIOTIDES
Live / Allowed — Published for opposition (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 05 Jun 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 79372781
- Mark type
- Stylized text
- Filed
- 05 Jun 2023
- Published for opposition
- 17 Mar 2026
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 001 — Chemicals: Peptides for industrial purposes for use in the research and development of pharmaceuticals
- Class 005 — Pharmaceuticals: Synthetic peptides for pharmaceutical purposes for the treatment and diagnosis of infectious diseases, pain, inflammation, cognitive disorders, cardiovascular, cardiopulmonary, oncological, respiratory, neurological, psychiatric, neurodegenerative diseases, and immune system related diseases and disorders and regenerative medicines
Owner
- JPT Peptide Technologies GmbH, BERLIN, DE
- JPT Peptide Technologies GmbH, BERLIN, DE
- JPT Peptide Technologies GmbH, DE
Prosecution history
- 17 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Mar 2026 — PUBLISHED FOR OPPOSITION
- 11 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
- 21 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 21 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
- 21 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
- 18 Feb 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 18 Feb 2026 — FINAL REFUSAL E-MAILED
- 18 Feb 2026 — FINAL REFUSAL WRITTEN
- 29 Jan 2026 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 30 Dec 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 15 Apr 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 01 Feb 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB